Luminex Says Q2 Revenues Rise 32 Percent as Profit Turns to Loss

Jul 26, 2007

NEW YORK (GenomeWeb News) — Luminex said Wednesday that second-quarter revenue increased 32 percent as R&D spending rose 116 percent and a modest profit turned to a loss.

Total receipts for the three months ended June 30 increased to $17.5 million from $13.3 million year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Main menu